skip to main content
OSTI.GOV title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: Inhibition of estrogen receptor {beta}-mediated human telomerase reverse transcriptase gene transcription via the suppression of mitogen-activated protein kinase signaling plays an important role in 15-deoxy-{delta}{sup 12,14}-prostaglandin J{sub 2}-induced apoptosis in cancer cells

Journal Article · · Experimental Cell Research
; ; ;  [1];  [1]
  1. Department of Clinical Laboratory Medicine, Sapporo Medical University School of Medicine (Japan)

The nuclear hormone receptor peroxisome proliferator-activated receptor (PPAR)-{gamma} plays a role in cancer development in addition to its role in glucose metabolism. The natural ligand of PPAR-{gamma}, namely, 15-deoxy-{delta}{sup 12,14}-prostaglandin J{sub 2} (15d-PGJ{sub 2}), has been shown to possess antineoplastic activity in cancer cells. However, the mechanism underlying its antineoplastic activity remains to be elucidated. Inhibition of the expression of human telomerase reverse transcriptase (hTERT), a major determinant of telomerase activity, reportedly induces rapid apoptosis in cancer cells. In this study, we investigated the effect of 15d-PGJ{sub 2} on hTERT expression. We found that 15d-PGJ{sub 2} induced apoptosis in the MIAPaCa-2 pancreatic cancer cells and dose-dependently decreased hTERT mRNA and protein expression. Down-regulation of hTERT expression by hTERT-specific small inhibitory RNA also induced apoptosis. Furthermore, 15d-PGJ{sub 2} attenuated the DNA binding of estrogen receptor (ER). MIAPaCa-2 expressed only ER{beta}, and although its expression did not decrease due to 15d-PGJ{sub 2}, its phosphorylation was suppressed. Additionally, a mitogen-activated protein kinase (MAPK) kinase inhibitor decreased ER{beta} phosphorylation, and 15d-PGJ{sub 2} attenuated MAPK activity. We conclude that hTERT down-regulation by 15d-PGJ{sub 2} plays an important role in the proapoptotic property of the latter. Furthermore, 15d-PGJ{sub 2} inhibits ER{beta}-mediated hTERT gene transcription by suppressing ER{beta} phosphorylation via the inhibition of MAP kinase signaling.

OSTI ID:
21045893
Journal Information:
Experimental Cell Research, Vol. 313, Issue 16; Other Information: DOI: 10.1016/j.yexcr.2007.06.028; PII: S0014-4827(07)00291-1; Copyright (c) 2007 Elsevier Science B.V., Amsterdam, The Netherlands, All rights reserved; Country of input: International Atomic Energy Agency (IAEA); ISSN 0014-4827
Country of Publication:
United States
Language:
English